These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11772249)

  • 1. Development of agents for the treatment of systemic sclerosis.
    Herrick AL
    Expert Opin Investig Drugs; 2001 Jul; 10(7):1255-64. PubMed ID: 11772249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis.
    Lin AT; Clements PJ; Furst DE
    Rheum Dis Clin North Am; 2003 May; 29(2):409-26. PubMed ID: 12841302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging drugs and therapeutics for systemic sclerosis.
    Lee JJ; Pope JE
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):421-430. PubMed ID: 27813423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting vascular disease in systemic sclerosis.
    Kowal-Bielecka O
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):401-7. PubMed ID: 17214586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis.
    Abraham D; Lescoat A; Stratton R
    Mol Aspects Med; 2024 Apr; 96():101252. PubMed ID: 38325132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleroderma - new aspects in pathogenesis and treatment.
    Balbir-Gurman A; Braun-Moscovici Y
    Best Pract Res Clin Rheumatol; 2012 Feb; 26(1):13-24. PubMed ID: 22424190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting fibrosis in systemic sclerosis.
    Lafyatis R
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):395-400. PubMed ID: 17214585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical approach to the therapy of systemic sclerosis.
    Czirják L
    Z Rheumatol; 2004 Dec; 63(6):451-6. PubMed ID: 15605208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis: an update.
    Varga J
    Bull NYU Hosp Jt Dis; 2008; 66(3):198-202. PubMed ID: 18937632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature.
    Giuggioli D; Lumetti F; Colaci M; Fallahi P; Antonelli A; Ferri C
    Autoimmun Rev; 2015 Nov; 14(11):1072-8. PubMed ID: 26209905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models in systemic sclerosis: an update.
    Bi X; Mills T; Wu M
    Curr Opin Rheumatol; 2023 Nov; 35(6):364-370. PubMed ID: 37605874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic sclerosis. A clinical overview.
    Generini S; Fiori G; Moggi Pignone A; Matucci Cerinic M; Cagnoni M
    Adv Exp Med Biol; 1999; 455():73-83. PubMed ID: 10599326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic sclerosis].
    Tamborrini G; Distler M; Distler O
    Med Monatsschr Pharm; 2008 May; 31(5):162-70; quiz 171-2. PubMed ID: 18552072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of systemic sclerosis: the art and science.
    Stone JH; Wigley FM
    Semin Cutan Med Surg; 1998 Mar; 17(1):55-64. PubMed ID: 9512108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of methotrexate in patients with scleroderma and mixed connective tissue disease.
    Kowal-Bielecka O; Distler O
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S160-3. PubMed ID: 21044452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy.
    Henry TW; Mendoza FA; Jimenez SA
    Autoimmun Rev; 2019 Nov; 18(11):102396. PubMed ID: 31520794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New trends in diagnosis and treatment of systemic sclerosis].
    Becvár R; Stork J; Jansa P
    Vnitr Lek; 2006; 52(7-8):712-7. PubMed ID: 16967613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis.
    Stenström M; Nyhlén HC; Törngren M; Liberg D; Sparre B; Tuvesson H; Eriksson H; Leanderson T
    J Dermatol Sci; 2016 Jul; 83(1):52-9. PubMed ID: 27156795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From mechanisms of action to therapeutic application: A review on current therapeutic approaches and future directions in systemic sclerosis.
    Del Papa N; Zaccara E
    Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):756-69. PubMed ID: 27107511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contemporary management of systemic sclerosis.
    Eldoma M; Pope J
    Expert Rev Clin Immunol; 2018 Jul; 14(7):573-582. PubMed ID: 29874475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.